Results 171 to 180 of about 8,209 (210)

Successful Treatment of Refractory Pityriasis Lichenoides Chronica with Upadacitinib in Two Patients.

Indian J Dermatol
Zeng X, Tong Z, Huang F, Bao C, Gong T, Ji C.   +5 more
europepmc   +1 more source

The use of Janus kinase inhibitors to treat noninfectious uveitis. [PDF]

Eye (Lond)
Beckman M, Srivastava SK, Lowder CY, Baynes K, Lowe A, Sharma S.   +5 more
europepmc   +1 more source

JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease. [PDF]

Therap Adv Gastroenterol
Fousekis FS, Jefremow A, Katsanos KH, Neurath MF, Atreya R.   +4 more
europepmc   +1 more source

Upadacitinib treatment of refractory livedoid vasculopathy: a case report and literature review. [PDF]

An Bras Dermatol
Zheng J, Liang X, Huang X, Liao J.
europepmc   +1 more source

Association between oral JAK-1 inhibitors and infection risks in atopic dermatitis: a retrospective analysis of the FAERS database. [PDF]

Front Med (Lausanne)
Tang Z, Mu Z, Wang X, Zhao Y.
europepmc   +1 more source

Treatment of Livedoid Vasculopathy with the Janus Kinase Inhibitors: A Case Series. [PDF]

Case Rep Dermatol
Zhao G, Liu Y, Ni J, Song Z.
europepmc   +1 more source

Targeting the JAK/STAT pathway in palmoplantar pustulosis: a review. [PDF]

Ann Med
Vimbai Chirindo C, Yun-Jie W, Tauseef H, Chao C, Tao Y.   +4 more
europepmc   +1 more source

Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study. [PDF]

JAAD Int
Anand P, Mostaghimi A, Glynn R, Jin Y, Merola JF, Silverberg JI, Rosmarin DM, Sidbury R, Landon J, Schneeweiss MC.   +9 more
europepmc   +1 more source